Macular Degeneration Flashcards

1
Q

Risk factors for AMD

A

age, family history, cataract surgery, smoking, native American ancestry, HTN, diabetes, lack of regular exercise (<3x a week)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is AREDS1

A

No AMD

  • Normal signs of again
  • No - few small drusen <63um.
  • 15% conversion to intermediate AMD within 10 years
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is AREDS2

A

Early AMD

  • Combination of:
    o Multiple small drusen
    o Few intermediate drusen (63-124um)
    o Mild RPE abnormalities
  • 15% conversion to intermediate AMD within 10 years
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is AREDS3

A
  • Many intermediate drusen
  • ≥1 large drusen (>125 um)
  • Geographic atrophy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is AREDS4

A
  • Geographic atrophy (involving foveal centre) - requires FA to exclude other inherited retinal disease.
  • Neovascularisation maculopathy: CNV, hard exudates, subretinal and sub RPE fibrovascular proliferation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

AREDS1 Management

A

Management: Observation only.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

AREDS2 Management

A
  1. Observation only
  2. Regular exercise (≥3x/week)
  3. Cease smoking.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

AREDS3 Management

A
  1. Dietary Advice
    a. Dark green leafy vegetable daily
    b. Oily fish 2 – 3 x a week
    c. Low GI carbohydrates
    d. Handful of nuts weekly
    e. Limit consumption of saturated fats/oils
  2. Regular exercise (≥3x/week)
  3. Cease smoking.
  4. Daily supplements:
    a. 500mg vitamin C
    b. 400IU vitamin E
    c. 15 mg Beta – carotene OR 10mg Lutein and 2mg zeaxanthin and 25mg zinc oxide
    d. 80mg zinc oxide (if usually beta – carotene)
    e. Copper (2mg as cupric oxide)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

AREDS4 Management

A
  1. Referral to ophthalmology for Anti – VEGF (ranibizumab or Aflibercept)
    a. May consider in combination with iRay radiation
    b. Risk of ischemic cardiac event (stroke), elevated IOP
  2. Potential Treatment
    a. Pegcetocoplan PM or PEOM injections
    b. Aracincaptad Pegol
    c. Gene therapy – factor B antisense with RNA target
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Calculate rate of progression to late AMD

A

Right eye
Large Drusen = 1
Pigment Change = 1

Left eye
Large Drusen = 1
Pigment Change = 1

0 = 0%
1 = 3%
2 = 9%
3 = 27%
4 = 43%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly